Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
ABTthis companyAbbott Laboratories	$109.98	33.5×	4.2×	4.94×	18.91×	22.3%	55.5%	18.2%	14.7%	12.5%	8.4%	3.4%	0.29×	0.55×	23.6×	1.58×	1.9%	6	3.29	2	C
BDXBecton, Dickinson and Company	$214.61	25.2×	1.66×	1.93×	12.21×	275.6%	45.4%	11.8%	7.7%	6.6%	4.7%	6.3%	0.76×	3.7×	4.21×	1.11×	2.8%	7	2.24	3	B
BSXBoston Scientific Corporation	$43.91	48.65×	5.82×	7.03×	29.7×	100.4%	69.0%	19.8%	14.4%	11.9%	8.8%	2.6%	0.51×	2.03×	11.38×	1.62×	0.0%	6	2.89	2	C+
DHRDanaher Corporation	$232.40	45.15×	3.08×	6.59×	25.3×	-14.1%	60.9%	20.9%	14.7%	6.9%	5.7%	3.2%	0.35×	1.99×	19.38×	1.87×	0.5%	7	3.74	3	B
EWEdwards Lifesciences Corporation	$103.97	46.33×	4.82×	8.22×	33.31×	-37.2%	78.1%	27.0%	17.7%	10.4%	11.4%	2.7%	0.07×	-1.56×	0×	3.72×	0.0%	6	12.89	3	B
GEHCGE HealthCare Technologies Inc.	$81.90	17.99×	3.61×	1.82×	11.34×	70.4%	40.0%	13.4%	10.1%	20.1%	8.8%	4.0%	0.96×	1.45×	6.14×	1.18×	0.2%	6	1.87	3	B+
Peer median	—	45.15×	3.61×	6.59×	25.3×	70.4%	60.9%	19.8%	14.4%	10.4%	8.8%	3.2%	0.51×	1.99×	6.14×	1.62×	0.2%	6	2.89	3	—